NSRX

NASUS PHARMA LTD

NSRX·M7071P109·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

NSRX (NASUS PHARMA LTD) is held by 6 institutional investors as of Q2 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($3.1M), Hudson Bay Capital Management LP ($471,699), CITADEL ADVISORS LLC ($77,014). Net institutional sentiment: Mixed.

6
Holders
$3.8M
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress: Updated regularly
NSRX

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 22, 2026 · Activists Aug 14, 2026 · Congress none

ActivistBALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.10.0%Aug 14, 2026
InsiderTBTeleman Dan BenjaminBuy $20KJun 17, 2026
ActivistBalyasny Asset Management L.P.Balyasny Asset Management L.P.10.0%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
898,473$3.1M0.0%-14.74%
0
Unchanged
134,771$471,6990.0%-14.74%
0
New
22,004$77,0140.0%+15.71%
33
New
16,640$58,2400.0%+15.71%
29
New
12,200$42,7000.0%+15.71%
28
Decreased
1,000(-50.0%)$3,5000.0%-46.36%
0
Exited
0(-100.0%)$86,0000.0%-26.32%
0
Exited
0(-100.0%)$6,8690.0%-31.27%
0
NSRXNSRXNASUS PHARMA LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used